Skip to main content
Clinical Trials/NCT05001594
NCT05001594
Completed
Not Applicable

The Effects of a Wearable Vibratory Device on Biomechanics, Quality of Life and Serum Biomarkers After an ACL Reconstruction Surgery

Technion, Israel Institute of Technology1 site in 1 country40 target enrollmentJanuary 30, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Injuries
Sponsor
Technion, Israel Institute of Technology
Enrollment
40
Locations
1
Primary Endpoint
Tampa Scale of Kinesiophobia (TSK)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Anterior cruciate ligament (ACL) injuries account for up to 25% of knee injuries, it is estimated that 32,000-400,000 new cases of ACL tears occur in the USA every year.

The Standard care is twofold; a) ACL reconstruction surgery and b) prolonged rehabilitation period (usually no less than 9 months). However, a large amount of patients do not return to their pre-injury activity level, and up to 30% reinjure their ACL in the following two years.

The wearable system consists of two non-invasive bands, above and below the knee that vibrate during the weight bearing phase while walking.

Detailed Description

The objective of this study is to investigate the effect of treatment for ACL reconstruction, including vibrational stimulation and pressure, on locomotion tasks (i.e. walking, stair ascending and descending), muscle function, and pain/function.

Registry
clinicaltrials.gov
Start Date
January 30, 2022
End Date
October 7, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Arielle Fischer

Assistant Professor

Technion, Israel Institute of Technology

Eligibility Criteria

Inclusion Criteria

  • Provision of signed and dated informed consent form
  • Males and females
  • Aged 18-50
  • Scheduled for an ACL reconstruction in Rambam hospital.
  • Hebrew language at mother tongue level

Exclusion Criteria

  • Inability to understand the study protocol.
  • Known neuropathies, active cancer, previous fractures in the lower limbs, inflammatory arthritis, implanted electronic devices of any kind.
  • Allergies to silver or adhesives.

Outcomes

Primary Outcomes

Tampa Scale of Kinesiophobia (TSK)

Time Frame: 6 months post op

The TSK total score ranges from 17 to 68, where 68 represents high kinesiophobia and 17 indicates no kinesiophobia

Lower limb joints range of motion (Degrees)

Time Frame: 6 months post op

Measured by Inertial measurement unit system

Knee strength (Newtons)

Time Frame: 6 months post op

Injured knee, quadriceps and hamstring

The International Knee Documentation Committee (IKDC) Subjective Knee Form

Time Frame: 6 months post op

The IKDC total score ranges from 0 to 100, where 100 indicates the highest levels of function and lowest levels of symptoms and 0 indicates the lowest level of function or highest level of symptoms.

General Anxiety Disorder-7 (GAD-7)

Time Frame: 6 months post op

The GAD-7 total score ranges from 0 to 21, where 21 represents high anxiety and 0 indicates no anxiety

Secondary Outcomes

  • Single-leg hop for distance (cm)(6 months post op)
  • Single-leg drop jump (cm)(6 months post op)
  • Serum Biomarkers (ng/mL)(4 months post op)
  • Surface Electromyography (EMG)(Pre-surgery)
  • Surface EMG(6 months post op)

Study Sites (1)

Loading locations...

Similar Trials